Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sloan Biotech Funds

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 1
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

Look at other 50 related and similar funds Collapse list ↓
Fund NameLocation
Brew House Delhi, India, New Delhi
Children's Health Dallas, Texas, United States
Chuling Chuangtou China, Hangzhou, Zhejiang
Cue Ball, LLC Boulder, Colorado, United States
Dirui Zichan China, Hangzhou, Zhejiang
G and M Capone Trust Adelaide, Australia, South Australia
Garena Central, Central Region, Singapore
INCISENT Labs Chicago, Illinois, United States
JointForce Fund Beijing, China, Haidian
KNet Investment Partners Seoul, Seoul-t'ukpyolsi, South Korea
Litorina Stockholm, Stockholm County, Sweden
National Securities Corporation New York, New York, United States
NCP Northland Capital Partners -
Parana Management Belgium, Oost-Vlaanderen, Sint-martens-latem
Robot Corp -
SWS Ventures Canada, Ontario, Toronto
T.N. Incorporation -
TechSquare Labs Atlanta, Georgia, United States
Zheng He Capital -
Zhuhai Weier Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Auspex Pharmaceuticals

$12M13 Oct 2010
Thomas, McNerney & Partners
CMEA Capital
Sloan Biotech Funds
 -
By posting comments on our website you confirm and acknowledge that:

1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.

2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.

3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.

4. We can moderate comments at any time.

5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.

6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.

Agree

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sloan Biotech Funds?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 18M
Peak activity year 2010
Lead investments 0
Follow on index 0.50
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Auspex Pharmaceuticals

$12M13 Oct 2010
Thomas, McNerney & Partners
CMEA Capital
Sloan Biotech Funds
 -
Crunchbase icon

Content report

The following text will be sent to our editors:

Send